Aquestive Therapeutics (AQST) Reports Q1 Loss, Misses Revenue Estimates
AQSTAquestive(AQST) Zacks Investment Research·2024-05-08 06:26

Aquestive Therapeutics (AQST) came out with a quarterly loss of 0.17pershareversustheZacksConsensusEstimateofalossof0.17 per share versus the Zacks Consensus Estimate of a loss of 0.09. This compares to earnings of 0.11pershareayearago.Thesefiguresareadjustedfornon−recurringitems.Thisquarterlyreportrepresentsanearningssurpriseof−88.890.11 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of -88.89%. A quarter ago, it was expected that this specialty pharmaceutical company would post a loss of 0.08 per share when it actually produced a loss of $0.12, delivering a surprise of -50%. Over the last fo ...